- Home
- ABVC vs REFR Comparison
ABVC vs REFR Comparison
Compare ABVC & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABVC | REFR |
|---|---|---|
| Founded | 2015 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.6M | 54.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ABVC | REFR |
|---|---|---|
| Price | $2.08 | $1.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 68.8K | 52.0K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $797,916.00 | ★ $1,227,276.00 |
| Revenue This Year | $735.18 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 56.52 | N/A |
| 52 Week Low | $0.40 | $0.93 |
| 52 Week High | $5.48 | $2.70 |
Technical Indicators
Market Signals| Indicator | ABVC | REFR |
|---|---|---|
| Relative Strength Index (RSI) | 31.30 | 38.27 |
| Support Level | $2.06 | $1.52 |
| Resistance Level | $2.30 | $1.69 |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 12.71 | 7.02 |
Price Performance
Historical ComparisonAbout ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.